Illumina False Claims Settlement Resolves Cyber Vulnerability Charge

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Illumina $9.8M False Claims Settlement Resolves Charge That Genome Devices Had Cyber Vulnerabilities

Dennis Tosh

July 31, 2025 at 01:06 PM EST

A manufacturer of genomic sequencing systems has agreed to pay $9.8 million to resolve allegations brought under the False Claims Act that systems sold to the federal government did not incorporate cybersecurity protections (United States ex rel. Lenore v. Illumina, Inc., No. 1:23-cv-00372-MSM-AEM (D.R.I.)). According to the Department of Justice (DOJ), cybersecurity vulnerab... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Illumina $9.8M False Claims Settlement Resolves Charge That Genome Devices Had Cyber Vulnerabilities

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT